Physician profile
Brian A Mailey
NPI 1376717603
$182,171.27
in general payments reported to CMS, 2019-2025
31 companies · $84K in 2025
The $84K reported for 2025 was more than what 99% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,549 · 2020: $18.01 · 2021: $75.88 · 2022: $1,170 · 2023: $40K · 2024: $56K · 2025: $84K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $60K · Consulting Fee: $56K · Travel and Lodging: $47K · Food and Beverage: $11K · Education: $4,857 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $450.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $59,615.21 |
| Consulting Fee | $56,312.50 |
| Travel and Lodging | $47,415.55 |
| Food and Beverage | $10,707.92 |
| Education | $4,857.12 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $450.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $95,987.29 | 2023-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Kerecis Limited | $75,942.88 | 2022-2025 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Surgiclose |
| Acumed LLC | $2,357.12 | 2025 | Innate Implant |
| Axogen | $1,824.30 | 2019-2024 | Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector |
| Abbvie INC. | $956.17 | 2023-2025 | |
| Ets Wound Care LLC | $634.69 | 2024-2025 | Mirragen Advanced Wound Matrix |
| Acera Surgical, INC. | $583.15 | 2023-2025 | Restrata Wound Matrix |
| Polynovo North America LLC | $470.38 | 2024-2025 | Novosorb Btm |
| Mentor Worldwide LLC | $467.33 | 2022-2025 | Artoura Breast Tissue Expander, Mentor Memorygel Resterilizable Gel Sizer, Mentor Cpx 2 Breast Tissue Expander |
| Depuy Synthes Sales INC. | $466.02 | 2022-2023 | Na, Va-Lcp |
| Wardlow Enterprises | $385.00 | 2019 | |
| Kls-Martin L.P. | $285.08 | 2019-2025 | |
| Stryker Corporation | $260.26 | 2021-2024 | Spy-Phi System, Conextions Tr Tendon Repair System-Implant Mechanism |
| Motiva USA, LLC | $225.48 | 2025 | |
| Allergan, INC. | $223.24 | 2020-2022 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanara Medtech INC. | $167.99 | 2025 | Celleraterx |
| Avita Medical Americas, LLC | $151.04 | 2025 | Permeaderm, Recell, Cohealyx |
| Kci USA, INC. | $140.72 | 2019-2023 | Prevena |
| Sientra, INC. | $120.95 | 2022 | |
| Tela Bio, INC. | $106.76 | 2024 | Ovitex 2s |
| Solventum Corporation | $87.58 | 2025 | Prevena, V.A.C.Ulta |
| Aroa Biosurgery Incorporated | $75.75 | 2025 | |
| Solta Medical, A Division of Bausch Health US, LLC | $40.15 | 2025 | |
| Musculoskeletal Transplant Foundation INC. | $32.00 | 2022 | |
| Vioptix INC | $31.61 | 2024-2025 | T. Ox Tissue Oximeter |
| Rti Surgical, INC | $31.39 | 2025 | |
| Endo USA, INC. | $29.85 | 2025 | Xiaflex |
| Lifenet Health | $25.15 | 2024 | Theragenesis Wound Matrix |
| Endo Pharmaceuticals INC. | $24.94 | 2023 | Xiaflex |
| Organogenesis INC. | $22.08 | 2024 | |
| Ethicon US, LLC | $14.92 | 2024 | Monocryl |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Mailey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.